Secretion of Novel SEL1L Endogenous Variants Is Promoted by ER Stress/UPR via Endosomes and Shed Vesicles in Human Cancer Cells
2011

New Variants of SEL1L in Cancer Cells

publication 10 minutes Evidence: moderate

Author Information

Author(s): Cattaneo Monica, Lotti Lavinia Vittoria, Martino Simone, Alessio Massimo, Conti Antonio, Bachi Angela, Mariani-Costantini Renato, Biunno Ida

Primary Institution: Institute for Biomedical Technologies, National Research Council, Milan, Italy

Hypothesis

The study investigates the secretion and role of novel SEL1L variants in human cancer cells under ER stress.

Conclusion

The two new SEL1L variants, p38 and p28, are secreted in cancer cells and may serve as potential diagnostic markers or therapeutic targets.

Supporting Evidence

  • p38 and p28 are more stable than the canonical SEL1LA protein.
  • Secretion of p38 is significantly increased under ER stress conditions.
  • P28 is only detected in the poorly differentiated SKBr3 breast cancer line after ER stress.

Takeaway

Scientists found two new proteins in cancer cells that help them deal with stress. These proteins could be important for understanding and treating cancer.

Methodology

The study involved biochemical and RNA interference studies in various human cancer cell lines to analyze the expression and secretion of SEL1L variants.

Limitations

The study primarily focuses on in vitro models, which may not fully replicate in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0017206

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication